How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.com68-Ga-FAPI-PET for Tumor Detection: A Prospective Observational Trial
Description:
This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.
Sponsor:
University Hospital, Essen
Contacts:
Wolfgang Fendler, MDwolfgang.fendler@uk-essen.de
+49 201 723 1862
Lukas Kessler, MDlukas.kessler@uk-essen.de
+49 201 723 1862
Government Study Link:
NCT04571086 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience